Bundamedik Tbk PT (BMHS) - Total Assets
Based on the latest financial reports, Bundamedik Tbk PT (BMHS) holds total assets worth Rp4.02 Trillion IDR (≈ $235.35 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check cash flow reinvestment rate of Bundamedik Tbk PT to assess the company's total reinvestment commitment from operating cash flow.
Bundamedik Tbk PT - Total Assets Trend (2018–2025)
This chart illustrates how Bundamedik Tbk PT's total assets have evolved over time, based on quarterly financial data. Check Bundamedik Tbk PT (BMHS) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Bundamedik Tbk PT - Asset Composition Analysis
Current Asset Composition (December 2025)
Bundamedik Tbk PT's total assets of Rp4.02 Trillion consist of 30.1% current assets and 69.9% non-current assets.
| Asset Category | Amount (IDR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rp0.00 | 20.6% |
| Accounts Receivable | Rp211.10 Billion | 5.3% |
| Inventory | Rp51.62 Billion | 1.3% |
| Property, Plant & Equipment | Rp2.51 Trillion | 62.5% |
| Intangible Assets | Rp0.00 | 0.0% |
| Goodwill | Rp94.79 Billion | 2.4% |
Asset Composition Trend (2018–2025)
This chart illustrates how Bundamedik Tbk PT's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Bundamedik Tbk PT.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Bundamedik Tbk PT's current assets represent 30.1% of total assets in 2025, an increase from 17.5% in 2018.
- Cash Position: Cash and equivalents constituted 20.6% of total assets in 2025, up from 8.0% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 0.0% in 2018.
- Asset Diversification: The largest asset category is property, plant & equipment at 62.5% of total assets.
Bundamedik Tbk PT Competitors by Total Assets
Key competitors of Bundamedik Tbk PT based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Fresenius Medical Care AG & Co. KGaA
XETRA:FME
|
Germany | €31.47 Billion |
|
Ramsay Health Care Ltd
AU:RHC
|
Australia | AU$21.70 Billion |
|
PACS Group, Inc.
NYSE:PACS
|
USA | $5.66 Billion |
|
RAMSAY HLTH.CARE ADR/025
F:RMY0
|
Germany | €22.48 Billion |
|
Top Choice Medical Investment Co Inc
SHG:600763
|
China | CN¥6.24 Billion |
|
Sanbo Hospital Management Group Ltd. A
SHE:301293
|
China | CN¥3.72 Billion |
|
Xian International Medical Investment Co Ltd
SHE:000516
|
China | CN¥9.50 Billion |
|
MLP Saglik Hizmetleri AS
IS:MPARK
|
Turkey | TL89.94 Billion |
Bundamedik Tbk PT - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.62 | 1.92 | 1.19 |
| Quick Ratio | 1.55 | 1.83 | 1.17 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Rp464.15 Billion | Rp520.46 Billion | Rp132.52 Billion |
Bundamedik Tbk PT - Advanced Valuation Insights
This section examines the relationship between Bundamedik Tbk PT's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.86 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 16.5% |
| Total Assets | Rp4.02 Trillion |
| Market Capitalization | $91.25 Million USD |
Valuation Analysis
Below Book Valuation: The market values Bundamedik Tbk PT's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Bundamedik Tbk PT's assets grew by 16.5% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Bundamedik Tbk PT (2018–2025)
The table below shows the annual total assets of Bundamedik Tbk PT from 2018 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Rp4.02 Trillion ≈ $235.35 Million |
+16.54% |
| 2024-12-31 | Rp3.45 Trillion ≈ $201.94 Million |
+11.78% |
| 2023-12-31 | Rp3.08 Trillion ≈ $180.66 Million |
+4.92% |
| 2022-12-31 | Rp2.94 Trillion ≈ $172.19 Million |
+9.34% |
| 2021-12-31 | Rp2.69 Trillion ≈ $157.48 Million |
+24.28% |
| 2020-12-31 | Rp2.16 Trillion ≈ $126.72 Million |
+54.38% |
| 2019-12-31 | Rp1.40 Trillion ≈ $82.08 Million |
+12.86% |
| 2018-12-31 | Rp1.24 Trillion ≈ $72.73 Million |
-- |
About Bundamedik Tbk PT
PT Bundamedik Tbk provides health care services in Indonesia. It also engages private hospital and healthcare support service activities; provision of ambulance services; private health education; consultant for reproductive technology services management; management consultant of physiotherapy service; and hotel, and dental clinic services management consulting businesses. It also provides ferti… Read more